|Key people||E. Thomas Arington|
Prasco is a pharmaceutical company headquartered in Cincinnati, Ohio, and founded in 2002 by E. Thomas Arington, former Chairman and CEO of Duramed Pharmaceuticals and former president of the healthcare consulting firm MarketMaster. The company remains privately held. It specializes in the field of authorized generics, generic drugs manufactured by the branded innovator company but marketed under a private label. According to IMS Health, the pharmaceutical industry auditing service, Prasco is one of the fastest growing pharmaceutical companies in the industry, in terms of relative growth and prescriptions dispensed for the years 2005 and 2006. Although it does not release financial data, $150 million in sales were tracked by an independent consulting company during 2005, reportedly doubling the previous years' figures.
Prasco has licensed generic versions of a variety of brand-name prescription drugs, including the antihistamine Allegra, progestin Cyclessa(used in combined oral contraceptive pills), the insomnia medication Ambien, GERD medication Protonix and others allowing them to be the leading authorized generic company with over 18 licensed products. The company has also funded public opinion research in the field of generic drugs, including a 2005 Roper Public Affairs & Media study that found a majority of Americans support the availability of generic alternatives.
- IMS National Sales Perspectives & National Prescription Audit, 2005, 2006
- Ritchie, James (2006-02-03). "Prasco's market share Rx: authorized generic drugs". Business Courier of Cincinnati.
- "Prasco in deal for generic Allegra" (fee required). Pharma Marketletter. 2005-07-01.
- "Prasco to market generic Allegra". Business Courier of Cincinnati. 2005-10-14.
- "Prasco ships generic Cyclessa" (fee required). Drug Topics. 2004-09-04.
- "Prasco Laboratories: Over 80 percent of Americans Want the Option of Authorized Generic Prescription Drugs; Research Underlines Consumer Demand to Have Authorized Generic Prescription Drugs Available" (fee required). Business Wire. 2005-07-01.